![(R)-9-(4-(1-(dimethylamino)propan-2-yl)phenyl)-8-hydroxythieno[2,3-c]quinolin-4(5H)-one hydrochloride structure, CAS 1338545-01-9](/structures/210000/194620_1_1338545_01_9.png)
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1338545-01-9 |
| Catalog No. | 2A-1193058 |
| Chinese Name | TOPK inhibitor-1 HCl |
| Synonyms | Exact Mass 414.116882; InChIKey QYYGPSOJFZCEPX-BTQNPOSSSA-N; Synonyms |
| Molecular Formula | C23H25O2N2Cl1S1 |
| Molecular Weight | 428.98 |
| Storage Condition | -20°C, sealed, dry |
| PubChem ID | 224685335 |
| MDL Number | MFCD28386220 |
| SMILES | CC(CN(C)C)c1ccc(-c2c(O)ccc3[nH]c(=O)c4sccc4c23)cc1.Cl |
| InChI | InChI=1S/C22H22N2O2S.ClH/c1-13(12-24(2)3)14-4-6-15(7-5-14)19-18(25)9-8-17-20(19)16-10-11-27-21(16)22(26)23-17;/h4-11,13,25H,12H2,1-3H3,(H,23,26);1H/t13-;/m0./s1 |
| InChI Key | QYYGPSOJFZCEPX-BTQNPOSSSA-N |
| MSDS | msds/194620_1_1338545_01_9.pdf |
| Transport Info | Product name: TOPK inhibitor-1 HCl |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| (S)-1-(3-Methyl-Piperazin-1-Yl)-Ethanone Hydrochloride | 1638137-85-5 | 2A-1192960 |
| 7-bromo-2-hydrazinylQuinoxaline | 145369-92-2 | 2A-1192999 |
| 7-Bromo-2-fluoroquinoxaline | 2251-59-4 | 2A-1193002 |
| tert-butyl (3R,4R)-rel-3-(benzylamino)-4-hydroxypyrrolidine-1-carboxylate | 1417175-15-5 | 2A-1193025 |
| Methyl (S)-2-(4-Hydroxyisoxazolidine-2-carbonyl)benzoate | 272459-61-7 | 2A-1193029 |
| (R)-N-Cbz-2-aMino-3-fluoropropanoic acid | 36369-34-3 | 2A-1193059 |
| (R)-N-Cbz-2-aMino-3-fluoropropanoic acid | 1235440-17-1 | 2A-1193060 |
| 3-chloro-5,6,7,8-tetrahydro-1,6-naphthyridine hydrochloride | 1260879-95-5 | 2A-1193071 |
| 6-broMo-4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyriMidine | 784150-40-9 | 2A-1193073 |
| (1R,2S,5S)-rel-3-[(tert-butoxy)carbonyl]-3-azabicyclo[3.1.0]hexane-2-carboxylic acid | 1051393-66-8 | 2A-1193104 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA